GlassScriptPhysician profile
Dean W Singer
NPI 1396131538
$863.23
in general payments reported to CMS, 2019-2025
10 companies · $69.78 in 2025
The $69.78 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.75 · 2022: $96.40 · 2023: $509 · 2024: $136 · 2025: $69.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $305.14 | 2022-2025 | Camzyos, Eliquis |
| Abbvie INC. | $186.15 | 2022-2023 | Ubrelvy, Qulipta, Botox |
| Kerecis Limited | $92.61 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Indivior INC. | $72.10 | 2022-2025 | Sublocade |
| Glaxosmithkline, LLC. | $51.36 | 2022-2025 | Shingrix, Bexsero, Arexvy |
| Exact Sciences Corporation | $46.80 | 2023-2024 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $40.59 | 2023 | |
| Amarin Pharma, INC. | $32.22 | 2021 | |
| Abbott Laboratories | $19.53 | 2021 | |
| Lilly USA, LLC | $16.73 | 2023 | Trulicity, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.